|
Home
|
E-Submission
|
Sitemap
|
Editorial Office
|
Aims and Scope
About the Journal
Editorial Board
Open Access
Best Reviewer Awardees
Article Processing Charge
Editorial Office
Instructions for Authors
Research and Publication Ethics
Checklist
E-Submission
Copyright Transfer Agreement
All issues
Accepted Articles
Epub Ahead-of Print Articles
Current Issue
Most Read Articles
Most Cited Articles
Cancer Research and Treatment
Search
Author Index
Cancer Research and Treatment
Search
> Browse Articles > Search
Gastrointestinal cancer
Specific Mutations in
APC
, with Prognostic Implications in
Metastatic Colorectal Cancer
Huan Peng, Jun Ying, Jia Zang, Hao Lu, Xiaokai Zhao, Pengmin Yang, Xintao Wang, Jieyi Li, Ziying Gong, Daoyun Zhang, Zhiguo Wang
Cancer Res Treat.
2023;55(4):1270-1280. Published online April 24, 2023 DOI:
https://doi.org/10.4143/crt.2023.415
Crossref 1
Trastuzumab Combined with Irinotecan in Patients with HER2-Positive
Metastatic Colorectal Cancer
: A Phase II Single-Arm Study and Exploratory Biomarker Analysis
Ting Xu, Xicheng Wang, Ying Xin, Zhenghang Wang, Jifang Gong, Xiaotian Zhang, Yanyan Li, Congcong Ji, Yu Sun, Feilong Zhao, Depei Huang, Yuezong Bai, Jian Li, Lin Shen
Cancer Res Treat.
2023;55(2):626-635. Published online December 23, 2022 DOI:
https://doi.org/10.4143/crt.2022.1058
Web of Science 5
Crossref 5
Thymidylate Synthase, Thymidine Phosphorylase, VEGF and p53 Protein Expression in Primary Colorectal Cancer for Predicting Response to 5-fluorouracil-based Chemotherapy
Myung-Ju Ahn, Jung-Hye Choi, Ho-Suk Oh, Young-Yeul Lee, In-Soon Kim, Il-Young Choi, Kang-Hong Lee, Kang-Won Song, Chan-Kum Park
Cancer Res Treat.
2005;37(4):216-222. Published online August 31, 2005 DOI:
https://doi.org/10.4143/crt.2005.37.4.216
Crossref 5
Phase II Study of Irinotecan, 5-Fluorouracil, and Leucovorin in Relapsed or
Metastatic Colorectal Cancer
as First-line Therapy
Young-Woong Won, Young-Hyo Lim, Ho-Yong Park, Ho-Suk Oh, Jung-Hye Choi, Young-Yeul Lee, In-Soon Kim, Il-Young Choi, Myung-Ju Ahn
Cancer Res Treat.
2004;36(4):235-239. Published online August 31, 2004 DOI:
https://doi.org/10.4143/crt.2004.36.4.235
Crossref 5
1
Journal Impact Factor 4.6